compar
analysi
synovi
fluid
plasma
proteom
juvenil
arthriti
proteom
pattern
joint
inflamm
earli
stage
diseas
around
one
everi
thousand
children
uk
suffer
juvenil
idiopath
arthriti
jia
worldwid
report
incid
vari
geograph
basi
per
usa
per
australia
jia
heterogen
group
inflammatori
disord
primarili
affect
musculoskelet
system
common
symptom
jia
persist
joint
swell
pain
stiff
jia
normal
affect
load
bear
joint
knee
foot
movement
limit
pain
advers
outcom
present
vari
degre
regardless
diseas
subtyp
persist
inflam
joint
major
risk
factor
main
outcom
includ
limit
joint
function
joint
structur
damag
due
eros
sever
case
disabl
death
jia
subtyp
vari
consider
pattern
sever
joint
inflamm
diseas
progress
outcom
typic
cours
subtyp
jia
one
exacerb
remiss
howev
may
one
two
flare
up
never
symptom
other
experi
repeat
flare
up
diseas
persist
activ
adulthood
jia
target
line
joint
synovi
membran
caus
inflamm
synov
synov
persist
joint
damag
may
occur
tissu
destruct
result
dysregul
molecular
level
synthesi
breakdown
matrix
compon
joint
cartilag
oligoarticular
diseas
children
manag
nsaid
intraarticular
steroid
inject
reliev
pain
inflamm
slow
prevent
joint
destruct
restor
joint
function
effect
manag
minim
effect
recurr
synov
howev
earli
accur
diagnosi
essenti
success
clinic
manag
induc
jia
patient
polyarticular
diseas
use
combin
antiinflammatori
treatment
nsaid
methotrex
mtx
even
nearli
half
patient
relaps
treatment
discontinu
rate
relaps
may
influenc
residu
synovi
inflamm
time
immunosuppress
treatment
withdrawn
diseas
clinic
remiss
import
know
possibl
withdraw
immunosuppress
drug
without
induc
flare
potenti
seriou
side
effect
clinician
three
main
concern
maintain
diseas
remiss
prevent
preempt
diseas
spread
ultim
avert
perman
joint
damag
disabl
predict
test
would
allow
diseas
progress
forecast
therefor
modifi
treatment
accordingli
signific
benefit
could
provid
patient
although
main
clinic
manifest
arthriti
destruct
joint
inflamm
mani
organ
may
target
inflammatori
process
holist
view
inclus
local
system
aspect
diseas
like
achiev
satisfactori
diseas
resolut
postul
biomark
may
exist
make
distinct
local
system
protein
express
pattern
across
diseas
subtyp
date
mean
identifi
appar
clinic
inact
patient
special
risk
relaps
current
definit
diseas
activ
jia
exclus
base
clinic
routin
laboratori
measur
consequ
larg
proport
patient
may
diagnos
rel
advanc
stage
diseas
restrict
clinician
abil
modifi
diseas
outcom
reduc
efficaci
therapeut
intervent
tradit
acut
phase
respons
marker
creactiv
protein
crp
erythrocyt
sediment
rate
esr
show
signific
differ
respond
nonrespond
steroid
even
earli
diseas
histopatholog
studi
jia
synovi
membran
indic
patient
diagnos
jia
exhibit
increas
vascular
b
cell
infiltr
hyperplasia
featur
evid
advanc
stage
inflammatori
process
sinc
sampl
within
current
studi
newli
diagnos
patient
month
potenti
opportun
character
earli
stage
diseas
work
proteom
arthrit
biolog
fluid
tissu
infanc
littl
inform
avail
juvenil
diseas
therefor
essenti
undertook
preliminari
work
demonstr
power
sensit
proteom
studi
differenti
express
protein
fluid
jia
pilot
studi
uncov
fragment
extracellular
matrix
tcell
receptor
protein
product
degrad
proteolyt
environ
recurr
inflam
knee
peptid
observ
indic
two
process
like
partli
interlinkedhypertroph
cartilag
breakdown
tcell
infiltr
predictor
mechan
arthrit
diseas
focus
area
cell
cytokin
fibroblast
proteas
osteoclast
clear
though
singl
agent
process
wholli
respons
rather
interact
process
result
characterist
protein
express
pattern
particular
inflammatori
natur
proteom
therefor
ideal
system
biolog
approach
examin
multifacet
process
work
arthriti
addit
multiplex
diagnost
like
reflect
true
complex
arthriti
diseas
process
fluoresc
differ
gel
electrophoresi
dige
appli
studi
spectral
distinct
cy
dye
fluorophor
permit
multiplex
correspond
synovi
fluid
plasma
individu
patient
inclus
intern
pool
standard
compos
experi
sampl
gel
allow
proteom
comparison
made
patient
biolog
variat
bodi
fluid
reliabl
quantifi
reason
propos
effici
biomark
diagnos
classifi
inflamm
local
within
affect
joint
hand
equal
import
assess
system
molecular
foundat
diseas
may
clinic
appar
practic
viewpoint
also
prefer
abl
quantifi
biomark
plasma
easili
access
less
trauma
children
particular
may
suffer
repeat
bout
joint
inflamm
plasma
proteom
compos
haemostat
protein
confin
vascular
system
also
transient
secret
protein
tissu
part
normal
developmentalag
process
diseas
proteom
profil
plasma
therefor
encod
physiolog
state
tissu
circul
around
howev
mani
author
caution
meaning
diagnost
plasma
protein
also
like
found
lowest
abund
sinc
releas
tissu
blood
tempor
spatial
restrict
move
upstream
plasma
biofluid
proxim
diseas
site
therefor
like
fruit
initi
phase
biomark
candid
discoveri
studi
concern
reveal
protein
marker
allow
us
track
process
inflamm
detail
importantli
dissect
synovi
protein
express
pattern
may
identifi
reliabl
predictor
jia
outcom
initi
perform
studi
protein
express
within
synovi
fluid
plasma
earli
jia
order
discov
novel
biomark
distinguish
local
system
compon
joint
inflamm
arthriti
subsequ
comparison
synovi
proteom
across
patient
subgroup
provid
evid
analysi
could
potenti
use
patient
stratif
even
prognosi
thirti
two
patient
juvenil
idiopath
arthriti
jia
accord
ilar
criteria
enter
studi
time
initi
sampl
children
oligoarticular
arthriti
rfve
polyarticular
arthriti
year
oligoarticular
extend
diseas
affect
joint
origin
assess
therefor
reclassifi
extend
oligoarticular
patient
patient
cohort
split
two
studi
group
proteom
comparison
synovi
fluid
versu
plasma
n
b
jia
subgroup
n
see
tabl
patient
demograph
studi
group
patient
examin
consult
rheumatologist
mr
confirm
diagnosi
purpos
studi
initi
synovi
fluid
children
diseas
durat
less
six
month
studi
intraarticular
steroid
triamcinolon
acetonid
inject
knee
perform
ultrasound
guidanc
gener
anesthet
dose
determin
size
joint
triamcinolon
hexacetonid
avail
time
studi
clinic
detail
record
includ
subtyp
jia
age
sex
diseas
durat
local
gener
diseas
activ
appropri
time
local
recurr
esr
crp
local
inflamm
defin
joint
swell
pain
physic
examin
synovi
fluid
sf
aspir
use
asept
techniqu
plasma
obtain
procedur
sf
plasma
sampl
immedi
centrifug
g
min
remov
particul
cellular
materi
aliquot
store
analyz
medic
ethic
committe
approv
obtain
studi
green
park
healthcar
trust
patient
assent
parent
inform
consent
given
protein
within
patient
fluid
extract
stabil
h
addit
mper
protein
extract
reagent
ad
make
volum
ml
prior
ief
sampl
appli
cm
immobilin
drystrip
ph
linear
immobil
ph
gradient
ipg
strip
rehydr
overnight
previou
run
ph
carrier
ampholyt
ipg
strip
reveal
protein
focus
within
ph
rang
first
dimens
separ
protein
isoelectr
focus
ief
perform
total
vh
w
limit
per
strip
includ
final
v
step
h
obtain
high
qualiti
resolut
valu
mean
standard
deviat
number
subject
subgroup
descriptor
oligo
oligoarticular
joint
less
involv
diagnosi
poli
polyarticular
joint
involv
diagnosi
extend
oligo
patient
becom
polyarticular
month
diagnosi
crp
creactiv
protein
esr
erythrocyt
sediment
rate
studi
patient
rheumatoid
factor
neg
ief
strip
equilibr
equilibr
two
minut
step
gentl
rock
urea
mm
tri
vv
glycerol
wv
sd
first
equilibr
step
wv
dithiotreitol
ad
reduc
agent
second
wv
iodoacetamid
includ
reduc
protein
streak
alkyl
postequilibr
ipg
strip
laid
singl
well
page
gel
cm
mm
thick
seal
agaros
w
v
run
buffer
mm
tri
mm
glycin
wv
sd
bromophenol
blue
second
dimens
separ
run
wgel
temperatur
control
h
bromophenol
blue
dye
front
reach
end
gel
two
prepar
pick
gel
isol
protein
identif
load
mg
unlabel
protein
consist
equal
amount
sampl
prepar
gel
stain
silver
colloid
coomassi
blue
malditof
nesimsm
respect
prelabel
protein
visual
use
imag
ge
healthcar
buck
uk
imag
scan
use
nm
laser
nm
band
pass
bp
filter
imag
scan
use
nm
laser
nm
bp
filter
imag
scan
use
nm
laser
emiss
filter
nm
gel
scan
nm
pixel
resolut
photomultipli
tube
set
pixel
intens
remain
given
cy
dye
gel
analysi
perform
progenesi
samespot
version
build
nonlinear
dynam
ltd
newcastl
upon
tyne
uk
softwar
compris
gel
warp
dige
normal
comparison
modul
briefli
singl
refer
gel
assign
gel
imag
spot
detect
remain
gel
imag
align
refer
spot
outlin
overlay
onto
imag
ensur
data
omit
earli
stage
landmark
spot
use
confirm
spot
match
across
gel
manual
verif
characterist
threedimension
peak
use
screen
dust
artifact
incorrectli
identifi
spot
protein
spot
imag
automat
link
three
cy
dye
imag
per
gel
spot
intens
volum
use
normal
spot
volum
normal
volum
nv
spot
gel
calcul
softwar
ratio
volum
label
sampl
label
intern
standard
progenesi
softwar
perform
log
transform
spot
volum
ratio
gener
normal
distribut
data
log
normal
volum
lnv
use
quantifi
differenti
express
spot
match
across
replic
sampl
set
normal
spot
volum
use
creat
master
gel
experiment
comparison
exampl
studi
group
ten
gel
imag
combin
creat
one
sf
one
plasma
master
gel
subsequ
qualit
subtract
plasma
match
synovi
fluid
master
gel
reveal
popul
protein
uniqu
overexpress
joint
quantit
differenti
spot
analysi
perform
master
gel
experiment
group
pairwis
comparison
made
establish
synovi
fluidtoplasma
intersubgroup
interpati
dye
variat
within
samespot
review
modul
comparison
filter
find
spot
p
valu
pair
ttest
b
greater
twofold
chang
express
group
c
correctli
match
least
six
patient
fold
chang
calcul
ratio
averag
lnv
studi
group
quantit
data
set
export
excel
spread
sheet
analys
use
epclust
http
wwwbioinfebceeepep
epclust
gener
data
cluster
visual
analysi
tool
genom
proteom
express
data
hierarch
analysi
allow
sampl
interindividu
protein
express
pattern
highli
similar
reorder
agglom
fashion
use
unweight
pairgroup
averag
upgma
cluster
procedur
method
distanc
two
cluster
calcul
averag
distanc
pair
object
two
differ
cluster
euclidean
distanc
similar
measur
use
group
separ
express
data
group
protein
express
level
present
form
heatmap
accompani
dendrogram
tree
branch
depict
extent
similar
differ
group
sampl
protein
spot
excis
silverstain
gel
digest
use
protocol
describ
briefli
gel
spot
wash
mmoll
nh
hco
acetonitril
follow
dehydr
acetonitril
protein
reduc
mmoll
mmoll
nh
hco
h
alkyl
mmoll
iodoacetamid
mmoll
nh
hco
h
room
temperatur
gel
piec
wash
sever
time
mmoll
nh
hco
follow
dehydr
acetonitril
protein
digest
overnight
trypsin
promega
modifi
trypsin
result
peptid
mixtur
analyz
malditof
mass
fingerprint
andor
malditoftof
peptid
sequenc
alphalys
odens
denmark
instrument
use
malditoftof
autoflex
iii
bruker
dalton
bremen
germani
mass
spectra
acquir
mz
scan
rang
mass
accuraci
calibr
within
ppm
use
calibr
standard
standard
peptid
calibr
mix
bruker
dalton
run
peaklist
gener
bruker
daltron
flexanalysi
softwar
use
sophist
numer
annot
procedur
snap
algorithm
signal
nois
ratio
qualiti
factor
median
baselin
subtract
peptid
mass
obtain
use
queri
nonredund
sequenc
databas
nrdbncbi
protein
identif
use
mascot
databas
search
program
version
list
exclud
contamin
ion
speci
restrict
use
nrdb
databas
contain
entri
maintain
updat
european
molecular
biolog
laboratori
databas
search
paramet
consid
trypsin
enzym
cleav
ctermin
side
kr
unless
next
residu
p
ii
fix
modif
iii
carbamidomethyl
cystein
oxid
methionin
variabl
modif
iv
miss
cleavag
permit
fix
modif
v
peptid
toler
set
ppm
precursor
ion
vi
da
mass
toler
fragment
ion
accept
criteria
pmf
base
identif
minimum
mascot
score
use
confid
interv
threshold
p
peptid
ion
identifi
studi
malditof
cid
msm
analysi
independ
match
singl
protein
entri
databas
protein
identif
independ
verifi
queen
univers
belfast
nanoelectrosprayion
nesimsm
similar
coommassi
colloid
blue
stain
gel
digest
peptid
extract
trifluoroacet
acid
acetonitril
ultrapur
water
sonic
min
gel
pellet
form
brief
centrifug
supernat
desalt
use
ziptip
pierc
biotechnolog
inc
rockford
usa
dehydr
sc
speed
vac
vacuum
evapor
savant
instrument
inc
hicksvil
usa
desalt
peptid
digest
subject
nesimsm
lcq
deca
ion
trapmass
spectromet
thermofinnigan
san
jose
usa
oper
dynam
exclus
via
lcq
tune
softwar
version
msm
data
record
mz
scan
rang
posit
polar
kv
collis
energi
msm
data
collect
xcalibur
version
integr
use
interact
chemic
inform
system
ici
peak
detect
algorithm
softwar
provid
finnigan
default
msm
ion
search
perform
mascot
search
engin
version
matrix
scienc
inc
boston
usa
use
databas
ncbinr
contain
sequenc
follow
standard
search
paramet
trypsin
cleavag
ii
fix
modif
iii
constraint
protein
mass
mass
valu
iv
peptid
msm
toler
set
da
respect
v
peptid
charg
set
miss
cleavag
permit
mascot
use
mows
score
algorithm
threshold
score
indic
ident
signific
would
expect
occur
random
frequenc
less
simultan
analysi
individu
pair
plasma
synovi
fluid
ten
patient
tabl
studi
group
use
initi
isol
jointspecif
protein
express
profil
without
introduc
bia
interindividu
differ
pilot
gel
reveal
major
protein
sampl
fluid
migrat
within
ph
rang
result
shown
characterist
pattern
protein
migrat
appar
gel
scan
synovi
fluid
plasma
sampl
see
fig
number
high
abund
protein
form
fig
dige
spot
per
gel
within
ph
rang
synovi
fluid
spot
filter
master
gel
reveal
protein
spot
predomin
synovi
fluid
plasma
attent
focuss
seri
synovi
fluid
protein
circl
red
plasma
protein
circl
blue
spot
remain
unmatch
express
twofold
higher
level
could
detect
correspond
fluid
interestingli
synovi
fluid
specif
protein
kda
wherea
plasma
specif
wider
molecular
weight
rang
kda
protein
spot
cut
replic
prepar
gel
malditof
nesimsm
use
ascertain
ident
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
seri
typic
charg
train
spread
protein
consist
previou
work
laboratori
interest
distinct
reveal
local
synovi
fluid
sf
system
plasma
molecular
signatur
juvenil
arthriti
subgroup
initi
visual
inspect
appar
one
predomin
set
high
molecular
weight
protein
present
blood
fibrinogen
princip
retain
within
blood
approxim
spot
per
synovi
fluid
gel
imag
spot
per
plasma
gel
imag
automat
detect
match
across
patient
samespot
softwar
analysi
upper
lower
limit
detect
cy
dye
stain
bodi
fluid
span
order
magnitud
protein
spot
uniqu
number
synchron
refer
gel
intens
differ
spot
match
synovi
plasma
master
gel
quantifi
normal
intern
standard
allow
real
comparison
individu
protein
spot
sampl
type
across
patient
cohort
master
gel
construct
sampl
type
gel
analysi
softwar
spot
filter
perform
highlight
spot
predomin
synovi
fluid
predomin
plasma
spot
predomin
sfpl
could
presum
origin
either
fluid
describ
sfpl
specif
number
protein
consist
synovi
plasma
specif
express
pattern
highlight
quantifi
demonstr
abil
reliabl
differenti
molecular
fingerprint
local
system
diseas
across
patient
group
gel
base
approach
spot
filter
rational
narrow
focu
preval
consist
pattern
appli
across
ten
patient
express
data
set
imag
area
master
gel
see
fig
demonstr
intersampl
variat
express
synovi
specif
protein
spot
synovi
fluid
absenc
plasma
sampl
seri
synovi
fluid
protein
plasma
protein
select
basi
express
twofold
higher
level
could
detect
within
correspond
fluid
interindividu
intersampl
type
variat
protein
repres
heatmap
form
fig
even
though
mani
protein
constitu
synovi
fluid
deriv
plasma
appear
enrich
synovi
fluid
born
higher
synovi
fluid
plasma
ratio
list
tabl
though
approxim
fold
dynam
rang
appar
highest
lowest
sf
pl
ratio
list
found
top
bottom
detect
rang
order
magnitud
interestingli
synovi
fluid
specif
protein
kda
wherea
plasma
specif
wider
molecular
weight
rang
kda
indic
fig
statist
signific
protein
differ
abund
two
sampl
type
one
individu
indic
p
valu
list
tabl
found
degre
proteom
variabl
across
individu
patient
bodi
fluid
sampl
date
result
publish
variabl
synovi
fluid
proteom
analys
dige
method
statist
analysi
interpati
varianc
reveal
synovi
specif
plasma
specif
spot
within
previous
describ
spot
trypsin
digest
initi
identifi
use
matrix
assist
laser
desorpt
ionis
malditof
confirm
nanoelectrospray
mass
spectra
nesimsm
correl
compil
peptid
data
matrixsci
number
match
peptid
collis
induc
dissoci
cid
ion
use
verifi
protein
ident
list
alongsid
sequenc
coverag
mascot
score
mascot
use
mows
score
algorithm
indic
ident
signific
would
expect
occur
random
frequenc
less
posit
control
spot
pick
gel
molecular
weight
marker
correctli
identifi
myoglobin
peptid
ion
sequenc
peak
list
found
tabl
subgroup
protein
consist
express
patient
studi
repres
imag
area
individu
gel
see
fig
demonstr
interindividu
variat
express
repres
synovi
specif
protein
spot
synovi
fluid
absenc
correspond
plasma
sampl
calcul
express
varianc
select
group
protein
standard
deviat
mean
express
percent
observ
standard
deviat
high
across
synovi
sampl
particular
eg
protein
dispar
evid
synovi
fluid
plasma
degre
variat
given
protein
eg
protein
gener
speak
given
protein
detect
level
synovi
fluid
vari
wider
scale
averag
plasma
averag
except
rule
evid
standard
deviat
certain
protein
across
patient
close
match
sampl
type
cluster
analysi
protein
identif
defin
synovi
fluid
proteom
studi
group
normalis
express
data
pool
protein
previous
select
due
two
fold
abund
one
fluid
fig
pairwis
comparison
made
establish
patienttopati
synovi
fluidtoplasma
dye
variat
statist
analysi
interpati
varianc
reveal
synovi
specif
plasma
specif
spot
within
subgroup
protein
consist
express
patient
studi
p
express
level
properdin
spot
visibl
section
gel
imag
individu
patient
synovi
fluid
plasma
b
sampl
log
normal
peak
volum
properdin
plot
patient
sampl
shown
c
first
ten
point
repres
synovi
fluid
level
latter
ten
point
repres
plasma
level
type
subject
hierarch
cluster
analysi
visual
express
characterist
across
patient
fluid
see
fig
cluster
algorithm
appli
distinguish
plasma
synovi
fluid
form
two
clear
block
plasma
synovi
fluid
abund
protein
top
bottom
halv
respect
group
coregul
protein
rapidli
identifi
absenc
presenc
pattern
demonstr
cluster
label
certain
group
patient
seem
form
smaller
cluster
wherebi
fluid
specif
express
pattern
appar
synovi
fluid
cluster
appar
region
label
agglom
natur
cluster
reorder
data
degre
similar
patient
strongest
protein
list
top
weakest
bottom
repres
construct
dendrogram
wherebi
shortest
arm
signifi
express
level
closest
interest
therefor
note
select
plasma
proteom
produc
consist
express
pattern
protein
select
abil
distinguish
one
fluid
anoth
cut
replic
silver
stain
prepar
gel
mass
spectrometri
use
ascertain
ident
protein
name
mass
spectrometri
data
fold
differ
fluid
variat
across
patient
compil
protein
tabl
detail
inform
identif
includ
peptid
ion
sequenc
identifi
includ
tabl
albumin
isoform
common
fluid
even
uniqu
express
trait
evid
class
ubiquit
blood
protein
certain
isoform
detect
exclus
plasma
synovi
fluid
albumin
speci
detect
plasma
synovi
fluid
could
distinguish
molecular
weight
ascertain
gel
imag
isoform
albumin
speci
kda
predomin
plasma
kda
abund
synovi
fluid
exampl
albumin
identifi
three
separ
gel
core
spot
posit
approxim
molecular
weight
kda
respect
fig
two
lower
molecular
weight
form
abund
synovi
fluid
fold
respect
convers
transthyretin
transferrin
chain
fragment
identifi
fold
higher
level
plasma
respect
sever
apolipoprotein
speci
amongst
protein
commonli
express
synovi
fluid
disproportion
synovi
abund
chain
c
apoliprotein
compar
chain
molecul
evid
sfpl
ratio
apolipoprotein
aii
ciii
precursor
also
detect
significantli
higher
level
synovi
fluid
two
isoform
antitrypsin
detect
molecular
weight
estim
rang
kda
spot
accord
gel
marker
furthermor
inter
alpha
trypsin
inhibitor
properdin
identifi
among
protein
enrich
within
synovi
fluid
number
protein
remain
unidentifi
probabl
attribut
low
protein
yield
gel
core
master
gel
construct
patient
subgroup
imag
analysi
softwar
spot
filter
perform
highlight
spot
predomin
particular
subgroup
attent
focuss
seri
synovi
fluid
protein
circl
label
fig
spot
express
twofold
higher
level
pairwis
comparison
patient
subgroup
statist
signific
anova
p
group
select
synovi
fluid
protein
fell
kda
molecular
weight
rang
certain
protein
predomin
two
patient
subgroup
eg
protein
abund
polyarticular
extend
oligoarticular
patient
subgroup
wherea
other
appar
predomin
singl
subgroup
eg
protein
polyarticular
protein
oligoarticular
patient
highlight
fig
multivari
analysi
subsequ
use
visual
interpati
intersubgroup
express
pattern
select
protein
spot
highlight
proteom
explor
hierarch
cluster
analysi
select
protein
visual
heat
map
form
fig
pearson
rank
correl
reveal
three
distinct
cluster
cluster
contain
protein
consist
express
extend
oligoarticular
polyarticular
patient
wherea
protein
cluster
predomin
polyarticular
subgroup
intriguingli
protein
cluster
consist
overexpress
oligoarticular
polyarticular
subgroup
rel
patient
diseas
extens
seem
conceiv
use
combin
three
distinct
cluster
within
synovi
fluid
proteom
could
use
differenti
diseas
subgroup
unpair
ttest
reveal
protein
signific
fluctuat
combin
two
patient
subgroup
p
valu
summar
tabl
establish
signific
protein
express
pattern
pertin
assign
ident
use
mass
spectrometri
mass
spectrometri
deriv
identif
intersubgroup
variat
select
protein
list
tabl
detail
inform
identif
includ
peptid
ion
sequenc
identifi
includ
tabl
order
highlight
protein
may
discrimin
diseas
extens
emphasi
place
statist
signific
correl
extend
oligoarticular
patient
ubiquit
protein
six
albumin
isoform
g
h
k
p
identifi
distinct
protein
spot
pick
gel
distribut
throughout
identifi
protein
cluster
predomin
cluster
within
cluster
albumin
isoform
k
express
p
p
p
fold
extend
oligoarticular
patient
compar
oligoarticular
subgroup
wherea
albumin
isoform
g
convers
underexpress
p
p
fold
respect
patient
diseas
extens
intriguingli
albumin
complex
nonsteroid
antiinflammatori
drug
nsaid
snaproxen
spot
number
detect
significantli
rais
level
extend
oligoarticular
contrast
oligoarticular
patient
similar
p
fold
p
differ
record
isoform
isol
two
distinct
protein
spot
apolipoprotein
ai
aii
significantli
overexpress
p
p
fold
respect
polyarticular
patient
contrast
oligoarticular
extend
oligoarticular
subgroup
cluster
transferrin
identifi
two
independ
protein
spot
repres
nonglycosyl
nlobe
form
chain
level
nonglycosyl
transferrin
rais
p
fold
patient
show
diseas
extens
wherea
transferrin
nlobe
display
invers
p
fold
less
rel
oligoarticular
patient
complement
compon
hemopexin
display
analog
overexpress
polyarticular
patient
balanc
alongsid
oligoarticular
extend
oligoarticular
subgroup
interestingli
point
view
jia
patholog
vitamin
bind
protein
detect
polyarticular
patient
significantli
overexpress
level
p
fold
compar
oligoarticular
patient
cluster
addit
sever
spot
identifi
immunoglobulin
ig
fragment
within
cluster
significantli
reduc
level
patient
diseas
extens
oligoarticular
patient
ig
heavi
chain
variabl
region
ig
light
chain
express
p
fold
extend
oligoarticular
subgroup
rel
oligoarticular
subgroup
ig
heavi
chain
variabl
region
concomitantli
overexpress
fold
polyarticular
patient
compar
extend
subgroup
number
protein
spot
remain
unidentifi
attribut
low
protein
yield
gel
core
extract
process
protein
peptid
activ
passiv
secret
shed
synovi
membran
accumul
synovi
fluid
potenti
biomark
could
therefor
enrich
within
fluid
rel
plasma
first
studi
group
shown
local
system
diseas
differenti
cluster
pattern
protein
consist
synovi
plasma
specif
express
pattern
discrimin
group
protein
express
least
twofold
differ
two
sampl
type
relev
find
patholog
inflammatori
arthriti
children
fragment
precursor
antiinflammatori
protein
endogen
proteas
inhibitor
albumin
complement
factor
identifi
among
number
inhibitori
acut
phase
protein
associ
signific
differ
local
system
express
pattern
level
transthyretin
transferrin
rais
plasma
wherea
apolipoprotein
ai
aii
ciii
convers
higher
synovi
fluid
rheumatoid
arthriti
patient
apolipoprotein
ai
plasma
level
lower
normal
control
wherea
agreement
find
level
increas
synovi
fluid
apo
ai
immunohistolog
stain
confin
perivascular
area
within
synovium
ra
patient
suggest
apo
ai
could
inhibit
product
proinflammatori
cytokin
product
may
limit
diseas
recurr
inhibit
interact
lymphocyt
monocyt
investig
plasma
patient
progress
stage
sever
acut
respiratori
syndrom
sar
reveal
apolipoprotein
ai
transthyretin
transfer
significantli
lower
level
normal
control
convalesc
patient
protein
belong
neg
acut
phase
protein
app
previou
studi
suggest
plasma
concentr
decreas
respons
inflamm
increas
rate
transcapillari
escap
degrad
protein
also
identifi
increas
level
cerebrospin
fluid
alzheim
diseas
patient
thought
function
plaqu
clearanc
suggest
transient
infiltr
neg
app
plasma
protein
may
partial
explain
relapseremiss
cycl
characterist
jia
form
inflammatori
arthriti
rais
level
properdin
compon
altern
complement
activ
pathway
detect
synovi
fluid
properdin
activ
compliment
absenc
immun
complex
stabil
convertas
complex
associ
engulf
foreign
particl
invad
cell
phagocyt
tissu
inflamm
macrophag
cell
abl
secret
properdin
synovi
fluid
therefor
infiltr
cell
like
sourc
rais
level
observ
increas
blood
protein
may
function
metabol
within
joint
certain
isoform
fragment
given
protein
may
detect
higher
anticip
level
concentr
gradient
may
also
contribut
rais
amount
select
protein
due
fluid
pressur
differenti
exist
blood
suppli
joint
joint
fluid
certain
amount
leaki
two
fluid
could
anticip
due
breakdown
integr
synovi
capillari
network
commonli
observ
rang
rheumat
disord
joint
inflamm
progress
signal
particular
biomark
like
diminish
distanc
diseas
particular
dilut
plasma
interpati
differ
observ
may
indic
dilut
protein
larger
volum
plasma
thu
gener
narrow
concentr
interv
previous
elud
heterogen
degre
joint
inflamm
may
result
differenti
rate
protein
turnov
across
studi
patient
studi
capillari
ultrafiltr
transsynovi
flow
rate
impli
macromolecular
select
featur
fenestr
membran
separ
synovi
fluid
plasma
synovi
fluid
format
driven
net
imbal
pressur
capillari
plasma
intraarticular
fluid
continu
drainag
replenish
intraarticular
space
ensur
synovi
fluid
proteom
remain
flux
although
capillari
ultrafiltr
base
solut
synovi
fluid
secret
made
local
synovi
line
cell
size
select
propos
theori
hyaluronan
line
synovi
space
abl
filter
protein
albumin
steric
exclus
rate
transsynovi
fluid
loss
molecular
siev
effect
determin
chain
length
hyaluronan
concentr
synovi
membran
surfac
observ
albumin
isoform
variabl
stage
degrad
across
synovi
fluid
plasma
may
reflect
molecular
siev
synovi
endothelium
joint
fluid
differenti
rate
degrad
two
fluid
studi
also
show
number
variabl
mwt
pi
isoform
albumin
speci
variabl
ratio
synovi
fluid
plasma
also
suggest
protein
subject
variabl
post
translat
modif
may
direct
proport
singl
gene
product
select
locat
relev
diseas
patholog
inter
alpha
trypsin
inhibitor
alpha
antitrypsin
identifi
higher
synovi
level
compar
plasma
may
repres
inher
antiproteolyt
charact
normal
synovi
fluid
possibl
protein
part
homeostat
neg
feedback
system
protect
joint
inflamm
inter
alpha
trypsin
inhibitor
alpha
antitrypsin
also
detect
alongsid
apolipoprotein
transferrin
transthyretin
speci
recent
studi
normal
osteoarthrit
synovi
fluid
support
find
provid
recent
studi
peptid
fragment
oa
synovi
fluid
identifi
similar
acut
phase
compon
apolipoprotein
f
precursor
inhibitor
serum
amyloid
untarget
analysi
peptid
perform
synovi
fluid
osteoarthr
patient
liquid
phase
reversedphas
nanolcm
suggest
peptid
degrad
product
could
reveal
clinic
relev
inform
activ
peptidas
proteas
within
inflam
joint
second
studi
group
b
jia
patient
subgroup
classifi
accord
ilar
criteria
segreg
earli
diseas
base
cluster
pattern
synovi
fluid
protein
extens
find
may
possibl
differenti
jia
patient
suffer
diseas
extens
within
first
year
diagnosi
diseas
subgroup
test
discriminatori
group
protein
express
least
twofold
differ
jia
patient
subgroup
relev
find
patholog
inflammatori
arthriti
children
sever
acutephas
protein
albumin
glycoprotein
immunoglobulin
compris
discriminatori
subproteom
substanti
evid
suggest
molecul
may
govern
wide
rang
inflammatori
pathway
relev
patholog
jia
number
inhibitori
acut
phase
protein
associ
signific
differ
jia
subgroup
express
pattern
compar
synovi
fluid
proteom
level
oligoarticular
patient
subgroup
apolipoprotein
ai
reduc
patient
extend
oligoarticular
diseas
wherea
apolipoprotein
aii
higher
latter
apolipoprotein
speci
significantli
higher
polyarticular
patient
rheumatoid
arthriti
patient
apolipoprotein
ai
level
increas
synovi
fluid
suggest
apo
ai
could
inhibit
product
proinflammatori
cytokin
product
may
limit
diseas
recurr
inhibit
interact
lymphocyt
monocyt
line
apolipoprotein
ai
level
extend
oligoarticular
patient
display
gener
trend
toward
reduc
transferrin
haptoglobin
complement
rel
two
patient
subgroup
support
assert
rel
abund
hostrespons
protein
could
involv
spread
inflamm
previous
unaffect
joint
rais
sera
level
protein
record
breast
cancer
patient
metastat
relaps
furthermor
leucin
rich
identifi
studi
observ
elev
level
along
acut
phase
protein
patient
sever
acut
respiratori
syndrom
vitamin
bind
protein
vdbp
identifi
synovi
fluid
reduc
level
found
plasma
reflect
limit
dialysi
joint
space
synovi
fluid
analysi
reveal
significantli
rais
level
vdbp
extend
oligoarticular
polyarticular
patient
subgroup
sampl
use
studi
taken
time
initi
knee
inflamm
therefor
relev
diseas
patholog
earli
diseas
data
provid
indic
synovi
fluid
proteom
profil
could
use
classifi
patient
base
exist
clinic
definit
virtu
definit
extend
oligoarticular
patient
subgroup
becom
polyarticular
month
initi
diagnosi
consid
predict
diseas
evolut
subgroup
discrimin
possibl
propos
protein
biomark
panel
abil
predict
diseas
cours
would
power
tool
limit
advers
outcom
diseas
extens
may
flag
patient
effectiveaggress
treatment
strategi
earlier
stage
diseas
process
current
possibl
author
consid
collect
sampl
earliest
stage
diseas
cours
import
featur
current
studi
vital
discoveri
biomark
describ
initi
diseas
process
may
also
act
sentinel
predict
subsequ
diseas
outcom
catalogu
protein
profil
ident
best
describ
joint
statu
diseas
progress
may
also
possibl
monitor
therapeut
respons
time
furthermor
joint
proteom
record
could
help
predict
diseas
spread
joint
damag
consid
heterogen
patient
outcom
jia
therapeut
suppress
synovi
joint
inflamm
neglect
system
compon
chronic
diseas
may
repres
best
possibl
way
manag
nonrespons
diseas
longer
last
remiss
could
possibl
take
system
sentinel
account
dige
techniqu
coupl
malditof
mass
spectrometri
limit
biomark
detect
within
approxim
dynam
rang
order
magnitud
altern
strategi
use
futur
investig
enrich
less
abund
protein
bodi
fluid
sampl
affin
deplet
synovi
fluid
partial
eluent
plasma
like
mimic
protein
concentr
rang
order
magnitud
reduc
dynam
rang
synovi
fluid
enrich
lower
abund
protein
serum
albumin
immunoglobulin
could
remov
affin
deplet
column
futur
investig
intact
partial
degrad
protein
peptid
fragment
like
leach
circul
plasma
low
molecular
weight
compon
could
enrich
size
exclus
revers
phase
chromatographi
protein
express
pattern
local
chronic
inflam
joint
may
potenti
identifi
patient
like
suffer
diseas
spread
multipl
joint
differ
note
current
valid
larger
independ
patient
cohort
altern
method
express
function
analysi
use
corrobor
proteom
find
protein
identifi
could
act
criteria
prevent
diseas
extens
allow
earlier
aggress
therapeut
intervent
